CRCA vs. DXYZ

Last updated Jun 4, 2026

CRCA (ProShares Ultra CRCL) is Leveraged Equities fund actively managed by ProShares, while DXYZ (Destiny Tech100 Inc) is a stock. At a 0.30 correlation, their price movements are largely independent.

Performance

CRCA vs. DXYZ - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in ProShares Ultra CRCL (CRCA) and Destiny Tech100 Inc (DXYZ). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, CRCA achieves a -25.37% return, which is significantly lower than DXYZ's 31.99% return.

CRCA

• 1D: -20.86%
• 1M: -48.25%
• YTD: -25.37%
• 6M: -39.99%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

DXYZ

• 1D: -14.40%
• 1M: 4.93%
• YTD: 31.99%
• 6M: 65.09%
• 1Y: -5.69%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

CRCA vs. DXYZ - Yearly Performance Comparison

	2026 (YTD)	2025
CRCA ProShares Ultra CRCL	-25.37%	-81.81%
DXYZ Destiny Tech100 Inc	31.99%	-1.19%

Correlation

The correlation between CRCA and DXYZ is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (All Time) Calculated using the full available price history since Aug 8, 2025	0.30

Return for Risk

CRCA vs. DXYZ — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DXYZ

DXYZ Risk / Return Rank: 40
DXYZ Sharpe Ratio Rank: 38
DXYZ Sortino Ratio Rank: 46
DXYZ Omega Ratio Rank: 45
DXYZ Calmar Ratio Rank: 36
DXYZ Martin Ratio Rank: 37

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CRCA vs. DXYZ - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra CRCL (CRCA) and Destiny Tech100 Inc (DXYZ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

Sharpe Ratios by Period

	CRCA	DXYZ	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	—	-0.06	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.47	0.60	-1.07

Drawdowns

CRCA vs. DXYZ - Drawdown Comparison

The maximum CRCA drawdown since its inception was -94.02%, roughly equal to the maximum DXYZ drawdown of -90.35%. Use the drawdown chart below to compare losses from any high point for CRCA and DXYZ.

Drawdown Indicators

	CRCA	DXYZ	Difference
Max Drawdown Largest peak-to-trough decline	-94.02%	-90.35%	-3.67%
Max Drawdown (1Y) Largest decline over 1 year	—	-51.50%	—
Current Drawdown Current decline from peak	-87.98%	-59.48%	-28.50%
Average Drawdown Average peak-to-trough decline	-69.26%	-68.57%	-0.69%
Ulcer Index Depth and duration of drawdowns from previous peaks	—	32.43%	—

Volatility

Volatility by Period

	CRCA	DXYZ	Difference
Volatility (1M) Calculated over the trailing 1-month period	—	61.86%	—
Volatility (6M) Calculated over the trailing 6-month period	—	80.27%	—
Volatility (1Y) Calculated over the trailing 1-year period	196.79%	98.20%	+98.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	196.79%	165.18%	+31.61%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	196.79%	165.18%	+31.61%

Dividends

CRCA vs. DXYZ - Dividend Comparison

CRCA's dividend yield for the trailing twelve months is around 2.32%, while DXYZ has not paid dividends to shareholders.

Position	TTM	2025
CRCA ProShares Ultra CRCL	2.32%	1.06%
DXYZ Destiny Tech100 Inc	0.00%	0.00%

Frequently Asked Questions

Can I hold both CRCA and DXYZ in my portfolio?

CRCA and DXYZ have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.